Movatterモバイル変換

[0]ホーム
URL:

NO20052496L - Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. - Google Patents

Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.

Info

Publication number
NO20052496L
NO20052496LNO20052496ANO20052496ANO20052496LNO 20052496 LNO20052496 LNO 20052496LNO 20052496 ANO20052496 ANO 20052496ANO 20052496 ANO20052496 ANO 20052496ANO 20052496 LNO20052496 LNO 20052496L
Authority
NO
Norway
Prior art keywords
preparation
drugs
methods
cgrp antagonists
salts
Prior art date
Application number
NO20052496A
Other languages
English (en)
Other versions
NO20052496D0 (no
Inventor
Eckhart Bauer
Henri Nico Doods
Klaus Rudolf
Stephan Georg Mueller
Dirk Stenkamp
Philipp Lustenberger
Kirsten Arndt
Alexander Dreyer
Marcus Schindler
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Publication of NO20052496D0publicationCriticalpatent/NO20052496D0/no
Publication of NO20052496LpublicationCriticalpatent/NO20052496L/no

Links

Classifications

Landscapes

Abstract

Foreliggende oppfinnelse angår CGRP-antagonister med den generelle formel (I) hvor A, U, V, W, X og R1 til R3 er definert som i krav 1, tautomerer, diastereomerer, enantiomerer, hydrater, blandinger derav og saltene derav så vel som hydrater av saltene, spesielt de fysiologisk akseptable salter derav med uorganiske eller organiske syrer, farmasøytiske preparater inneholdende disse forbindelser, anvendelse derav og fremgangsmåter for fremstilling av dem.
NO20052496A2002-10-252005-05-24Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.NO20052496L (no)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
DE10250080ADE10250080A1 (de)2002-10-252002-10-25Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
PCT/EP2003/011762WO2004037810A1 (de)2002-10-252003-10-23Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Publications (2)

Publication NumberPublication Date
NO20052496D0 NO20052496D0 (no)2005-05-24
NO20052496Ltrue NO20052496L (no)2005-06-24

Family

ID=32103086

Family Applications (1)

Application NumberTitlePriority DateFiling Date
NO20052496ANO20052496L (no)2002-10-252005-05-24Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.

Country Status (27)

CountryLink
EP (1)EP1558600B1 (no)
JP (1)JP4401296B2 (no)
KR (1)KR20050074970A (no)
CN (1)CN1708493A (no)
AR (1)AR041718A1 (no)
AT (1)ATE394392T1 (no)
AU (1)AU2003276156A1 (no)
BR (1)BR0315665A (no)
CA (1)CA2503455A1 (no)
CO (1)CO5570704A2 (no)
DE (2)DE10250080A1 (no)
DK (1)DK1558600T3 (no)
EA (1)EA009219B1 (no)
EC (1)ECSP055747A (no)
ES (1)ES2306918T3 (no)
HR (1)HRP20050364A2 (no)
IL (1)IL168056A0 (no)
MX (1)MXPA05004375A (no)
NO (1)NO20052496L (no)
PE (1)PE20040592A1 (no)
PL (1)PL376450A1 (no)
RS (1)RS20050311A (no)
TW (1)TW200413317A (no)
UA (1)UA79323C2 (no)
UY (1)UY28034A1 (no)
WO (1)WO2004037810A1 (no)
ZA (1)ZA200502248B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE19963868A1 (de)*1999-12-302001-07-12Boehringer Ingelheim PharmaNeue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US7345068B2 (en)2002-02-072008-03-18Hitoshi EndouAromatic amino acid derivatives and medicinal compositions
US7220862B2 (en)2002-06-052007-05-22Bristol-Myers Squibb CompanyCalcitonin gene related peptide receptor antagonists
US7842808B2 (en)2002-06-052010-11-30Bristol-Myers Squibb CompanyAnti-migraine spirocycles
US7595312B2 (en)2002-10-252009-09-29Boehringer Ingelheim Pharma Gmbh & Co. KgSelected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
CA2531407A1 (en)*2003-07-072005-01-20Boehringer Ingelheim International GmbhUse of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients
TW200524601A (en)2003-12-052005-08-01Bristol Myers Squibb CoHeterocyclic anti-migraine agents
TW200533398A (en)*2004-03-292005-10-16Bristol Myers Squibb CoNovel therapeutic agents for the treatment of migraine
DE102004015723A1 (de)*2004-03-292005-10-20Boehringer Ingelheim PharmaAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004018795A1 (de)2004-04-152005-10-27Boehringer Ingelheim Pharma Gmbh & Co. KgAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102004018796A1 (de)*2004-04-152005-11-03Boehringer Ingelheim Pharma Gmbh & Co. KgAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7696195B2 (en)2004-04-222010-04-13Boehringer Ingelheim International GmbhSelected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
EP1794133B1 (en)*2004-09-092011-12-14Merck Sharp & Dohme Corp.Aryl spirolactam cgrp receptor antagonists
US7384931B2 (en)2004-11-032008-06-10Bristol-Myers Squibb CompanyConstrained compounds as CGRP-receptor antagonists
US7384930B2 (en)2004-11-032008-06-10Bristol-Myers Squibb CompanyConstrained compounds as CGRP-receptor antagonists
US7449586B2 (en)2004-12-032008-11-11Bristol-Myers Squibb CompanyProcesses for the preparation of CGRP-receptor antagonists and intermediates thereof
DE102004063753A1 (de)*2004-12-292006-07-13Boehringer Ingelheim Pharma Gmbh & Co. KgVerwendung ausgewählter CGRP-Antagonisten in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne
DE102004063755A1 (de)*2004-12-292006-07-20Boehringer Ingelheim Pharma Gmbh & Co. KgVerwendung von CGRP-Antagonisten zur Behandlung und Vorbeugung von Hitzewallungen bei Patienten mit Prostatakrebs
DE102004063752A1 (de)*2004-12-292006-07-13Boehringer Ingelheim Pharma Gmbh & Co. KgVerwendung ausgewählter CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen
US7491717B2 (en)2005-03-232009-02-17Boehringer Ingelheim International GmbhSelected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
CN101146799A (zh)*2005-03-232008-03-19贝林格尔·英格海姆国际有限公司Cgrp拮抗剂、其制备方法以及其作为药物的用途
EP1770091A1 (de)*2005-09-292007-04-04Boehringer Ingelheim Pharma GmbH & Co. KGCGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7439237B2 (en)2005-04-152008-10-21Boehringer Ingelheim International GmbhSelected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
DE102005038831A1 (de)*2005-08-172007-02-22Boehringer Ingelheim Pharma Gmbh & Co. KgAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7834007B2 (en)2005-08-252010-11-16Bristol-Myers Squibb CompanyCGRP antagonists
EP1770087A1 (de)*2005-09-292007-04-04Boehringer Ingelheim Pharma GmbH & Co. KGAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1770086A1 (de)*2005-09-292007-04-04Boehringer Ingelheim Pharma GmbH & Co. KGAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102005050892A1 (de)*2005-10-212007-04-26Boehringer Ingelheim Pharma Gmbh & Co. KgAusgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE102006017827A1 (de)2006-04-132007-10-18Boehringer Ingelheim Pharma Gmbh & Co. KgNeue kristalline Verbindungen
CN101500653A (zh)2006-06-082009-08-05贝林格尔.英格海姆国际有限公司使用cgrp拮抗剂对胃肠道病症的治疗
DE102007038250A1 (de)2007-08-132009-02-19Boehringer Ingelheim Pharma Gmbh & Co. KgNeues Herstellverfahren
EP2065381A1 (de)2007-10-182009-06-03Boehringer Ingelheim Pharma GmbH & Co. KGCGRP Antagonisten
JP5366960B2 (ja)2007-10-182013-12-11ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツングＣｇｒｐアンタゴニスト
EP2251338A3 (de)2007-11-222011-06-08Boehringer Ingelheim International GmbHOrganische Verbindungen
KR101409076B1 (ko)2008-08-012014-06-18미쓰이가가쿠 아그로 가부시키가이샤아미드 유도체, 그 아미드 유도체를 함유하는 유해 생물 방제제 및 유해 생물의 방제 방법
US8796334B2 (en)2009-02-162014-08-05Nogra Pharma LimitedMethods of treating hair related conditions
CN104254327A (zh)2012-02-092014-12-31诺格拉制药有限公司治疗纤维化的方法
EP3495363B1 (en)2016-07-282023-08-23Shionogi & Co., LtdNitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
DK3668853T3 (da)*2017-08-162021-12-06Glaxosmithkline Ip Dev LtdNye forbindelser
US11578084B2 (en)2018-01-262023-02-14Shionogi & Co., Ltd.Condensed ring compounds having dopamine D3 receptor antagonistic effect
SI3921299T1 (sl)2019-02-082025-03-31Nogra Pharma LimitedPostopek izdelave 3-(4'-aminofenil)-2-metoksipropionske kisline in njenih analogov in vmesnih proizvodov

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2000018764A1 (en)*1998-09-302000-04-06Merck Sharp & Dohme LimitedBenzimidazolinyl piperidines as cgrp ligands
DE19937304C2 (de)*1999-08-102003-08-21Boehringer Ingelheim PharmaVerwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen

Also Published As

Publication numberPublication date
JP2006516244A (ja)2006-06-29
CO5570704A2 (es)2005-10-31
CA2503455A1 (en)2004-05-06
EA009219B1 (ru)2007-12-28
ES2306918T3 (es)2008-11-16
AR041718A1 (es)2005-05-26
MXPA05004375A (es)2005-07-05
UY28034A1 (es)2004-05-31
AU2003276156A1 (en)2004-05-13
EP1558600A1 (de)2005-08-03
HRP20050364A2 (en)2006-05-31
KR20050074970A (ko)2005-07-19
DK1558600T3 (da)2008-09-01
EP1558600B1 (de)2008-05-07
WO2004037810A1 (de)2004-05-06
TW200413317A (en)2004-08-01
BR0315665A (pt)2005-08-30
EA200500600A1 (ru)2006-02-24
RS20050311A (sr)2007-08-03
DE50309807D1 (de)2008-06-19
IL168056A0 (en)2009-02-11
UA79323C2 (en)2007-06-11
ATE394392T1 (de)2008-05-15
ZA200502248B (en)2006-08-30
DE10250080A1 (de)2004-05-13
PE20040592A1 (es)2004-10-27
NO20052496D0 (no)2005-05-24
JP4401296B2 (ja)2010-01-20
ECSP055747A (es)2005-07-06
CN1708493A (zh)2005-12-14
PL376450A1 (en)2005-12-27

Similar Documents

PublicationPublication DateTitle
NO20052496L (no)Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter.
NO20052493L (no)Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
NO20064166L (no)Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
TW200606151A (en)Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
NO20062713L (no)2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
NO20023161L (no)Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem
NO20044826L (no)Pyrrolidinderivater
NO20061839L (no)Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
NO20060146L (no)Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
WO2002098856A3 (en)Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
NO20060147L (no)Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20060195L (no)Kinolylamidderivater som CCR-5-antagonister
NO20070432L (no)Pyrimidinureaderivater som kinaseinhibitorer
NO20071137L (no)Nye piperidinderivater for behandling av depresjon
NO20045486L (no)Nye forbindelser og deres anvendelse
ECSP045378A (es)Derivados novedosos de diazabiciclononeno
NO20076680L (no)Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
NO20062491L (no)Benzoksazinderivter og deres anvendelse
WO2004014869A3 (en)5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
TW200603799A (en)Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
TW200800962A (en)Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
NO20070837L (no)Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
NO20040881L (no)Orale antidiabetes midler.
YU30902A (sh)Novi ciklopropani kao cgrp antagonisti, lekovi koji sadrže navedena jedinjenja i postupak za njihovu proizvodnju
NO20060718L (no)Substituerte tiofoner og deres anvendelse

Legal Events

DateCodeTitleDescription
FC2AWithdrawal, rejection or dismissal of laid open patent application
[8]ページ先頭
©2009-2025 Movatter.jp